Brazilian multicenter study on pegvisomant treatment in acromegaly

Boguszewski, Cesar L; Huayllas, Martha Katherine P; Vilar, Lucio; Naves, Luciana Ansaneli; Ribeiro-Oliveira Junior, Antonio; Soares, Beatriz Santana; Czepielewski, Mauro Antonio; Abucham, Julio; Correa-Silva, Silvia Regina; Bronstein, Marcello Delano; Jallad, Raquel Soares; Duarte, Felipe Gaia; Musolino, Nina Rosa; Kasuki, Leandro; Gadelha, Monica Roberto.
Arch. endocrinol. metab. (Online) ; 63(4): 328-336, July-Aug. 2019. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1019350

Documentos relacionados

  1. Brazilian multicenter study on pegvisomant treatment in acromegaly.
  2. Effect of Cabergoline Treatment on Disease Control in Acromegaly Patients.
  3. Pegvisomant in acromegaly: a multicenter real-life study in Argentina.
  4. A systematic literature review to evaluate extended dosing intervals in the pharmacological management of acromegaly.
  5. Pegvisomant in acromegaly: a multicenter real-life study in Argentina
  6. Medical Therapy of Acromegaly in Germany 2019 - Data from the German Acromegaly Registry.
  7. COMPARISON OF CABERGOLINE VERSUS RALOXIFENE ADD-ON THERAPY TO LONG-ACTING SOMATOSTATIN ANALOGUE IN PATIENTS WITH INADEQUATELY CONTROLLED ACROMEGALY: A RANDOMIZED OPEN LABEL CLINICAL TRIAL.
  8. Pegvisomant and cabergoline combination therapy in acromegaly.
  9. The efficacy of medical treatment in patients with acromegaly in clinical practice.
  10. Long-term safety and treatment outcomes of pegvisomant in Japanese patients with acromegaly: results from the post-marketing surveillance.